• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAstraZeneca

AstraZeneca

Page 9 of 13
Syringe shown against the AstraZeneca logo
HealthAstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
HealthFor AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
Resurgent airlines, energy and bank stocks lead the way as the vaccine rally intensifies
NewslettersResurgent airlines, energy and bank stocks lead the way as the vaccine rally intensifies
By Bernhard WarnerNovember 24, 2020
Stocks and futures jump on AstraZeneca’s vaccine breakthrough. Here are the big winners
NewslettersStocks and futures jump on AstraZeneca’s vaccine breakthrough. Here are the big winners
By Bernhard WarnerNovember 23, 2020
AstraZeneca says its Covid-19 vaccine is up to 90% effective
HealthAstraZeneca says its Covid-19 vaccine is up to 90% effective
By Jeremy KahnNovember 23, 2020
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
HealthOxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
By James Paton, Suzi Ring and BloombergNovember 19, 2020
The vaccine rally is on pause, even slowing Bitcoin’s march
NewslettersThe vaccine rally is on pause, even slowing Bitcoin’s march
By Bernhard WarnerNovember 19, 2020
A line of syringes shown in silhouette against the AstraZeneca corporate logo.
FinanceAstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth
By Jeremy KahnNovember 6, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
HealthAstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
COVID vaccine science
HealthThe science behind the leading COVID vaccine candidates
By Sy MukherjeeNovember 3, 2020
Global stocks fall, dollar rises as stimulus talks fade and COVID cases spike
NewslettersGlobal stocks fall, dollar rises as stimulus talks fade and COVID cases spike
By Bernhard WarnerOctober 26, 2020
AstraZeneca cleared by U.S. regulators to resume COVID vaccine trial
HealthAstraZeneca cleared by U.S. regulators to resume COVID vaccine trial
By BloombergOctober 23, 2020
Participant who died in AstraZeneca trial had not been given vaccine
HealthParticipant who died in AstraZeneca trial had not been given vaccine
By Timothy Annett, Walter Brandimarte and BloombergOctober 22, 2020
Medical syringe is seen with 'covid-19' sign displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
HealthAs COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By David MeyerOctober 15, 2020
Photo of U.S. Speaker of the House Nancy Pelosi wearing a mask and gesturing with her hands.
HealthA Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca
By Jeremy KahnOctober 12, 2020
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...13
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.